Clinical Trial Update: Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on Betamethasone Microsphere for diabetic macular edema in Phase 2/Phase 3 (TSUBASA), focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Betamethasone Microsphere (betamethasone microsphere)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: COMPLETED